Geographic Atrophy Overview

Save information for later
Sign Up

Learn About Geographic Atrophy

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Geographic Atrophy Local Doctors?
Elite in Geographic Atrophy
Ophthalmology
Elite in Geographic Atrophy
Ophthalmology

Duke Health Integrated Practice Inc

2301 Erwin Rd, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Glenn Jaffe is an Ophthalmologist in Durham, North Carolina. Dr. Jaffe and is rated as an Elite provider by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Trabeculectomy. Dr. Jaffe is currently accepting new patients.

Ursula M. Erfurth-Schmidt
Elite in Geographic Atrophy
Elite in Geographic Atrophy
Vienna, AT 

Ursula Erfurth-Schmidt practices in Vienna, Austria. Erfurth-Schmidt and is rated as an Elite expert by MediFind in the treatment of Geographic Atrophy. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.

 
 
 
 
Learn about our expert tiers
Learn More
Frank G. Holz
Elite in Geographic Atrophy
Elite in Geographic Atrophy
University Of Bonn Ernst Abbe Str. 2, 
Bonn, NW, DE 

Frank Holz practices in Bonn, Germany. Holz and is rated as an Elite expert by MediFind in the treatment of Geographic Atrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, Vitrectomy, and Trabeculectomy.

What are the latest Geographic Atrophy Clinical Trials?
Randomized, Double-masked, actiVE-contRolleD, Multicenter Study to evaluAte Efficacy aNd safeTy of Two Regimens of Intravitreal BI 771716 Against Pegcetacoplan in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration VERDANT Trial

Summary: This study is open to people 50 years or older with an eye condition called geographic atrophy. The purpose of this study is to compare a medicine called BI 771716 with a medicine called pegcetacoplan. BI 771716 is being developed to treat people with geographic atrophy. Pegcetacoplan is a medicine already used to treat people with geographic atrophy. In this study, participants receive either BI ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Summary: A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration